MENLO PARK, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, at 5:00 pm Eastern Time. The call will be webcast and may be accessed at PacBio’s website at https://investor.pacificbiosciences.com/. Date: Thursday, February 12, 2026, at 5:00 pm ET (2:00 pm PT) Listen live via internet or replay: https://investor.pacificbiosciences.com/ ...

WESTFIELD, Mass., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Western New England Bancorp, Inc. (the “Company” or “WNEB”) (NasdaqGS: WNEB), the holding company for Westfield Bank (the “Bank”), announced today the unaudited results of operations for the three and twelve months ended December 31, 2025. For the three months ended December 31, 2025, the Company reported net income of $5.2 million, or $0.26 per diluted share, compared to net income of $3.3 million, or $0.16 per diluted share, for the three months ended De ...

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- At the end of the settlement date of January 15, 2026, short interest in 3,515 Nasdaq Global MarketSM securities totaled 15,349,969,813 shares compared with 15,183,396,236 shares in 3,498 Global Market issues reported for the prior settlement date of December 31, 2025. The mid-January short interest represents 2.88 days compared with 2.83 days for the prior reporting period. Short interest in 1,669 securities on The Nasdaq Capital MarketSM totaled 3,478,325,627 sh ...

WINTER PARK, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a leader in institutional-grade tokenization of real-world assets and commodity-backed stablecoins, including GLDY, today announced the closing of the sale of 1,750,000 shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriters in connection with its previously announced underwritten public offering, including a group of technology and minin ...

$10 MILLION UPFRONT WITH UP TO APPROXIMATELY $15 MILLION OF POTENTIAL AGGREGATE PROCEEDS UPON THE EXERCISE IN FULL OF WARRANTSTHORNTON, Colo., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Ascent Solar Technologies, Inc. (NASDAQ: ASTI) (“Ascent” or the “Company”), today announced the closing of its previously announced private placement for the purchase and sale of an aggregate of 1,818,182 shares of common stock (or pre-funded warrants in lieu thereof), series A warrants to purchase up to 1,818,182 shares of common st ...

Millicom (Tigo) announces successful bid for EPM’s Stake in UNE Luxembourg, January 27,2026 — Millicom International Cellular S.A. ("Millicom") today announced that it has been awarded 100% of EPM’s remaining shares in UNE EPM Telecommunicaciones S.A. (“UNE” or “Tigo Colombia”), following a winning bid in the public auction conducted by Empresas Públicas de Medellín E.S.P. ("EPM"). Millicom’s bid was COP 418,741 per share, representing a total consideration of approximately COP 2.1 trillion, (approximately ...

FISCAL Q3 2026 HIGHLIGHTS $1.4 MillionNet Income$0.07Diluted Earnings per Common Share$6.62Tangible Book Value per Share0.07%NPAs to Total Assets Fiscal Third Quarter Comparison Highlights Net Interest Income and Net Interest Margin $10.5 million net interest income for the quarter compared to $9.4 million in Fiscal Q3 2025Net interest margin at 2.96% for the quarter compared to 2.60% in Fiscal Q3 2025 Credit Quality Non-performing assets at 0.07% of total assets and 0.03% of total loans in Fiscal Q3 2026$ ...

Core Viewpoint - Rakovina Therapeutics Inc. is undergoing significant corporate updates, including leadership changes, debt restructuring, and financing initiatives to strengthen governance and enhance capital markets execution [1]. Debt Restructuring - The maturity date of the 12.0% convertible debentures, totaling $1,454,000, has been extended from January 28, 2026, to March 11, 2026, with consent from holders representing at least 66 2/3% of the outstanding principal [2][3]. - The company plans to restructure the outstanding 2023 Debentures, offering holders the option to convert their debentures into new Replacement Debentures or settle through a shares-for-debt conversion at $0.12 per share [4][5]. - An agreement in principle has been reached with an existing investor for an additional $1.0 million investment through a private placement of unsecured convertible debentures [7]. Financing Initiatives - The company proposes a concurrent private placement of up to 5,000,000 common shares at $0.12 per share, aiming for additional gross proceeds of up to $500,000 [9]. - The proceeds from the private placements will be used for near-term working capital to support ongoing corporate activities and strategic initiatives [10]. Leadership Changes - Kim Oishi has been appointed as the new Chief Executive Officer and will also join the Board of Directors, bringing extensive experience in public company leadership and capital markets strategy [11][12]. - Frank Holler has been appointed as an independent director, contributing significant expertise in life sciences and governance [16][18][21]. - Jeffrey Bacha will continue as the non-executive Chair of the Board, ensuring continuity and strategic oversight [13][15]. Board Composition - Dr. Dennis Brown has stepped down from the Board but will continue as Chair of the Scientific Advisory Committee, while Al DeLucrezia has also stepped down but will remain as an advisor [23][24]. - The Board's recent changes are aimed at enhancing governance and supporting the company's strategic initiatives in oncology [25][26]. Company Overview - Rakovina Therapeutics is focused on developing innovative cancer treatments that target the DNA damage response, utilizing advanced computational chemistry and AI-enabled drug discovery platforms [27].

Core Insights - World of Concrete 2026 successfully brought together over 47,400 registered professionals and more than 1,300 exhibitors, highlighting the event's significance in the concrete construction and masonry industries [1][2] Industry Growth - The cement and concrete products market is projected to reach $508 billion by 2030, with a compound annual growth rate (CAGR) of 4.9% [2] - 284 new exhibitors participated, showcasing innovative solutions across various product categories, including material handling, construction technology, and concrete reinforcement [2] Global Participation - The event featured participation from countries such as Australia, Canada, China, Germany, and the United Kingdom, emphasizing the global demand for concrete and masonry construction [3] Educational Initiatives - The education program introduced bilingual seminars and new engineering courses focused on construction efficiency and strategic design choices, enhancing skill development within the industry [5][7] - Notable sessions included an economic forecast that provided insights into market projections and sector-specific intelligence [6] Fundraising and Competitions - The Construction Industry Management (CIM) initiative raised a record-breaking $2.3 million to support students pursuing degrees in Concrete Industry Management [8] - The World Championship SPEC MIX BRICKLAYER 500 featured 28 masons competing for significant cash prizes and recognition [9] Future Events - World of Concrete will return to the Las Vegas Convention Center from January 19-21, 2027, with educational sessions starting on January 18 [13]

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Makarora Management LP (“Makarora”) today announced that, together with Ares Alternative Credit funds (“Ares”), it has completed the previously announced acquisition of Plymouth Industrial REIT, Inc. (“Plymouth”) in an all-cash transaction valued at approximately $2.1 billion. Pursuant to the terms of the transaction, Plymouth shareholders will receive cash consideration of $22.00 per share. With the completion of the acquisition, Plymouth will no longer be traded ...